NO20030841D0 - En ny spesifikk mekanisme for inhibering av blodplateadhesjon til kollagen - Google Patents

En ny spesifikk mekanisme for inhibering av blodplateadhesjon til kollagen

Info

Publication number
NO20030841D0
NO20030841D0 NO20030841A NO20030841A NO20030841D0 NO 20030841 D0 NO20030841 D0 NO 20030841D0 NO 20030841 A NO20030841 A NO 20030841A NO 20030841 A NO20030841 A NO 20030841A NO 20030841 D0 NO20030841 D0 NO 20030841D0
Authority
NO
Norway
Prior art keywords
platelet adhesion
saratin
collagen
inhibition
specific mechanism
Prior art date
Application number
NO20030841A
Other languages
English (en)
Other versions
NO331326B1 (no
NO20030841L (no
Inventor
Christopher Barnes
Matthias Frech
Uwe Hoffmann
Johannes Gleitz
Wolfgang Strittmatter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20030841L publication Critical patent/NO20030841L/no
Publication of NO20030841D0 publication Critical patent/NO20030841D0/no
Publication of NO331326B1 publication Critical patent/NO331326B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
NO20030841A 2000-08-25 2003-02-24 Anvendelse av saratin til fremstilling av et medikament for inhibering av blodplateadhesjon til kollagen NO331326B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00118542 2000-08-25
PCT/EP2001/009746 WO2002015919A2 (en) 2000-08-25 2001-08-23 Saratin for inhibiting platelet adhesion to collagen

Publications (3)

Publication Number Publication Date
NO20030841L NO20030841L (no) 2003-02-24
NO20030841D0 true NO20030841D0 (no) 2003-02-24
NO331326B1 NO331326B1 (no) 2011-11-28

Family

ID=8169664

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030841A NO331326B1 (no) 2000-08-25 2003-02-24 Anvendelse av saratin til fremstilling av et medikament for inhibering av blodplateadhesjon til kollagen

Country Status (27)

Country Link
US (2) US6881722B2 (no)
EP (1) EP1311284B1 (no)
JP (1) JP4988131B2 (no)
KR (1) KR100794277B1 (no)
CN (1) CN1224421C (no)
AR (1) AR030492A1 (no)
AT (1) ATE285246T1 (no)
AU (2) AU9550601A (no)
BR (1) BR0113478A (no)
CA (1) CA2419385C (no)
CZ (1) CZ302353B6 (no)
DE (1) DE60107962T2 (no)
DK (1) DK1311284T3 (no)
EC (1) ECSP034485A (no)
ES (1) ES2234896T3 (no)
HK (1) HK1059736A1 (no)
HU (1) HU229367B1 (no)
MX (1) MXPA03001604A (no)
MY (1) MY128992A (no)
NO (1) NO331326B1 (no)
PT (1) PT1311284E (no)
RU (1) RU2302880C2 (no)
SI (1) SI1311284T1 (no)
SK (1) SK287829B6 (no)
UA (1) UA77402C2 (no)
WO (1) WO2002015919A2 (no)
ZA (1) ZA200302296B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301524B6 (cs) * 1999-03-18 2010-03-31 Merck Patent Gmbh Polypeptid z H. medicinalis, zpusob jeho prípravy a použití, farmaceutický prostredek, polynukleotid, expresní vektor, hostitelská bunka, protilátka a její použití
CN101412759A (zh) 2003-01-10 2009-04-22 埃博灵克斯股份有限公司 治疗性多肽,其同源物、其片段及其在调节血小板介导的聚集方面的应用
WO2007038749A2 (en) 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
US20080069774A1 (en) * 2005-11-17 2008-03-20 Lance Liotta Proteomic antisense molecular shield and targeting
CN117229423B (zh) * 2023-11-10 2024-02-06 北京科技大学 一种用于结合胶原的多肽纳米材料及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947401A (en) * 1971-10-05 1976-03-30 Union Optics Corporation Hydrogels of unsaturated ester copolymers
US5705355A (en) * 1984-03-27 1998-01-06 Transgene, S.A. Hirudin, pharmaceutical compositions comprising it and their use
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
US5304121A (en) * 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
CA2052486A1 (en) * 1990-10-09 1992-04-10 Thomas M. Connolly Protein for inhibiting collagen-stimulated platelet aggregation
GB9022040D0 (en) 1990-10-10 1990-11-21 Biopharm Ltd Platelet adhesion inhibitor
US5179082A (en) * 1990-11-13 1993-01-12 Merck & Co., Inc. Method for blocking platelet adhesion to collagen
DE4136513A1 (de) 1991-11-06 1993-05-13 Basf Ag Neues thrombininhibitorisches protein aus raubwanzen
PT662088E (pt) * 1993-07-01 2002-06-28 Merck Patent Gmbh Inibidor da agregacao de plaquetas estimulada por colagenio
DK0711158T4 (da) * 1993-07-29 2008-11-03 Us Gov Health & Human Serv Metode til behandling af atherosclerose eller restenose ved anvendelse af mikrotubulus-stabiliserende middel
US5532287A (en) * 1994-05-04 1996-07-02 Ciba-Geigy Corporation Radiation cured drug release controlling membrane
US6246715B1 (en) * 1998-06-26 2001-06-12 Samsung Electronics Co., Ltd. Data transmitter and receiver of a DS-CDMA communication system
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
IL142539A0 (en) * 1998-10-16 2002-03-10 Immunex Corp Inhibitors of platelet activation and recruitment
IT1304135B1 (it) * 1998-11-26 2001-03-07 Magneti Marelli Spa Metodo di controllo dell' iniezione e dell' accensione in un motoreendotermico ad iniezione diretta per accelerare il riscaldamento del
BR0008298A (pt) * 1999-02-19 2002-02-19 Zymogenetics Inc Métodos para promover o fluxo sanguìneo dentro da vasculatura de um mamìfero, para pacificar tecidos colagenosos danificados dentro de um mamìfero, para pacificar a superfìcie de um biomaterial prostático para uso em associação com um mamìfero, e para mediar a reparação de feridas em um mamìfero
CZ301524B6 (cs) 1999-03-18 2010-03-31 Merck Patent Gmbh Polypeptid z H. medicinalis, zpusob jeho prípravy a použití, farmaceutický prostredek, polynukleotid, expresní vektor, hostitelská bunka, protilátka a její použití

Also Published As

Publication number Publication date
CN1224421C (zh) 2005-10-26
ZA200302296B (en) 2004-06-30
MXPA03001604A (es) 2003-06-04
SI1311284T1 (no) 2005-08-31
EP1311284B1 (en) 2004-12-22
DE60107962D1 (de) 2005-01-27
JP2004506690A (ja) 2004-03-04
MY128992A (en) 2007-03-30
NO331326B1 (no) 2011-11-28
PL359246A1 (en) 2004-08-23
KR20030034141A (ko) 2003-05-01
BR0113478A (pt) 2003-07-15
SK287829B6 (sk) 2011-11-04
EP1311284A2 (en) 2003-05-21
KR100794277B1 (ko) 2008-01-11
SK3132003A3 (en) 2003-08-05
AU2001295506B2 (en) 2007-02-15
NO20030841L (no) 2003-02-24
WO2002015919A2 (en) 2002-02-28
US20050143305A1 (en) 2005-06-30
ES2234896T3 (es) 2005-07-01
CA2419385A1 (en) 2002-02-28
CA2419385C (en) 2011-05-10
US6881722B2 (en) 2005-04-19
UA77402C2 (en) 2006-12-15
US20030190342A1 (en) 2003-10-09
AR030492A1 (es) 2003-08-20
CZ2003720A3 (cs) 2003-06-18
HUP0303747A2 (hu) 2004-03-01
RU2302880C2 (ru) 2007-07-20
WO2002015919A3 (en) 2002-05-30
US7459438B2 (en) 2008-12-02
PT1311284E (pt) 2005-05-31
HUP0303747A3 (en) 2006-01-30
JP4988131B2 (ja) 2012-08-01
AU9550601A (en) 2002-03-04
CZ302353B6 (cs) 2011-03-30
ECSP034485A (es) 2003-03-31
ATE285246T1 (de) 2005-01-15
CN1449291A (zh) 2003-10-15
DE60107962T2 (de) 2005-12-15
HK1059736A1 (en) 2004-07-16
DK1311284T3 (da) 2005-04-18
HU229367B1 (en) 2013-11-28

Similar Documents

Publication Publication Date Title
PA8506101A1 (es) Uso de un compuesto acat para fabricar una composicion farmaceutica
TR200401545T4 (tr) NOSS inhibitörü ilaçların amalatı için ikame imidazo [1,2-a]piridin-,-pirimidin- ve-pirazin-3-amin-türevlerinin kullanımı
ATE428372T1 (de) Beschichtung von stents zur verhinderung von restenose
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
HUP0002175A1 (hu) Xa-faktor inhibitorok alkalmazása önmagában vagy vérlemezkeaggregáció-gátló szerrel kombinálva artéria trombózis megelőzésére és kezelésére
DE50109226D1 (de) Dermales therapeutisches system enthaltend nichtsteroidale antiphlogistika mit selektiver cox-2-hemmung
ATE438361T1 (de) Stent beschichtet mit dna
WO2003072154A8 (en) Composition and method for coating medical devices
NO20030841D0 (no) En ny spesifikk mekanisme for inhibering av blodplateadhesjon til kollagen
SE9600216D0 (sv) Styrning av läkningsprocesser
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
IS6130A (is) Bólgueyðandi meðhöndlun fyrir bólgu tengt smit
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
BR0114276A (pt) Derivados de benzodiazepina ou sais destes farmaceuticamente aceitáveis, agente para inibir o fator x de coagulação do sangue ativado, composição farmacêutica, e, inibidor da coagulação sanguìnea ou um agente para prevenir ou tratar a trombose ou o embolismo
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
PT1187612E (pt) Utilizacao do riluzole para o tratamento da esclerose multipla
NO992985L (no) Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon
ATE361757T1 (de) Stabile fumagillin-formulierung
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
NO20012849D0 (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt
GEP20074101B (en) Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
AR027958A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades vasculares, que comprende propionil l-carnitina y coenzima q10

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees